Please provide your email address to receive an email when new articles are posted on . Corynebacterium accolens, a benign lipid-requiring bacterium, hydrolyzes skin surface triacylglycerols, ...
- Development of Intercell's Streptococcus pneumoniae vaccine supported by PATH VIENNA, April 7 /PRNewswire/ -- Intercell AG (VSE: ICLL) announced today that a Phase I clinical trial with the ...
Pneumococcal diseases, caused by the bacteria Streptococcus pneumoniae, are serious infections that can have a debilitating impact on your health. The bacteria are spread person-to-person through ...
FOSTER CITY, Calif., March 26, 2020 /PRNewswire/ -- SutroVax, a biopharmaceutical company dedicated to the delivery of superior and novel vaccines designed to prevent or treat some of the most common ...
REINACH, SWITZERLAND--(BUSINESS WIRE)--Vaxxilon, a privately held company working on synthetic vaccines, has been awarded a grant of up to $1.4 million from CARB-X, with the possibility of $3.1 ...
The American Society of Health-System Pharmacists (ASHP) supports the establishment of state and national surveillance systems to track the prevalence of drug-resistant Streptococcus pneumoniae so ...
Initiation of a first-in-man Phase I clinical trial in healthy subjects Study aims to obtain safety and immunogenicity data of this new vaccine candidate Initial results expected in Q4 2009 ...
Pneumonia is an infection that affects one or both lungs. The disease can range from mild to severe and can be fatal. It is typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback